Scaling up, cashing out – the routes to growth and exit in a transformed care home market

Cheap capital is gone and the regulators are emboldened: value in the UK care home market now flows to those who build competition, funding and workforce discipline into every growth and exit plan.

The UK care home sector has rarely been more capital-rich, or more closely watched. In 2025, investment into UK healthcare real estate climbed past £12 billion – the highest figure on record and roughly four times the prior five-year average – with US real estate investment trusts (REITs) the dominant force.[1] Welltower alone committed more than £7 billion, including the £5.2 billion purchase of the Barchester real estate portfolio, among the largest care home transactions ever completed globally.[2]

That weight of capital sits against a backdrop of relentless structural demand: an ageing population, a shortage of modern stock and steadily rising acuity. For operators looking to scale, and for investors planning an eventual exit, the opportunity is real. So are the headwinds. Financing costs remain elevated, the regulatory landscape has shifted decisively, government funding policy is unresolved and the workforce model the sector relied on for a decade has been withdrawn. This article maps the principal routes for growth and exit, and the opportunities and risks attaching to each.

Debt-funded acquisitions and new development

For much of the last cycle, cheap debt was the engine of consolidation. That engine has not stalled, but it has become far more expensive to run. With the ten-year gilt hovering close to 5% for much of 2025, leverage has only been accretive where asset yields reached the 6–7%-plus range, and institutional buyers operating at the sharper end of the yield curve have become notably selective.[3] The practical consequence is that highly leveraged UK and European bidders have repeatedly been outcompeted by US REITs able to transact on equity, often effectively debt-free, at price points a conventional leveraged structure simply cannot support.[4]

New development tells a similar story. Demand plainly exceeds supply, yet completions remain stubbornly low – only around 77 new homes were built in the most recent period – held back by a drawn-out planning process, elevated build costs and the limited commercial appeal of areas where private-pay demand is thin.[5] Development finance is available for the right scheme, with the right operator covenant, in a strong private-pay catchment, but lenders are discriminating and the gap between viable and unviable sites has widened.

The outlook is more constructive. If the anticipated reductions in interest rates materialise through 2026, the arithmetic improves for leveraged buyers and for domestic REITs that have been quieter while US capital led. For operators, debt remains a route to scale – but growth funded by ever-cheaper borrowing is, for now, behind us. Covenant headroom, refinancing risk and the interaction between rising fee income and rising cost bases all warrant closer scrutiny than in the previous cycle.

Triple-net leases from REITs

The triple-net (NNN) lease has long been the workhorse of healthcare real estate. The REIT owns the property and grants the operator a long lease under which the tenant bears substantially all the costs – rent, repairs, insurance and outgoings – typically with upward-only, often inflation-linked, rent reviews. For the investor, the attraction is clean, predictable, index-linked income with limited operational exposure. For the operator, a sale-and-leaseback releases capital tied up in freehold to fund acquisitions, refurbishment or shareholder returns, while retaining day-to-day control of the business.

The central risk in the current climate is rent cover. Triple-net rents are fixed obligations that do not flex when operating margins are squeezed – and margins are under real pressure from wage inflation, higher employer National Insurance contributions and constrained local-authority fee settlements. Where rent was set on assumptions about occupancy, fee growth and staffing costs that no longer hold, cover can erode quickly and a lease that looked secure on day one can become a source of distress. For investors, the quality and durability of the operator covenant – not just the headline yield – is now the decisive factor. For operators contemplating a sale-and-leaseback as a scaling tool, the level and indexation of the rent, and the realism of the underlying trading assumptions, deserve careful legal and commercial stress-testing before signature.

The RIDEA model

The structure reshaping the market is RIDEA – named after the US REIT Investment Diversification and Empowerment Act of 2007 – under which a REIT can hold not only the real estate but also an interest in the operating performance of the business, usually through a management contract with a third-party operator and a taxable REIT subsidiary.[6] Instead of a fixed rent, the REIT shares in the operational upside (and downside). This is the model Welltower has deployed at scale in the UK, pairing its property acquisitions with operating partners such as Care UK; the Barchester transaction combined long-term RIDEA and triple-net arrangements.

The appeal is twofold. RIDEA lets investors capture the value created by improving occupancy, fee mix and efficiency, rather than ceding it to the operator. And, crucially, it allows well-capitalised US REITs – helped by their cheaper capital base and their facility with these structures – to underwrite transactions at prices that fixed-rent UK and European REITs cannot match, a significant reason for the transatlantic imbalance in recent deal flow. The corollary is greater operational exposure: returns now track trading performance, so the choice of operating partner, the management agreement terms, incentive alignment and performance protections become central. The market increasingly describes this as ‘sale and manage-back’ – higher potential returns in exchange for operational risk a traditional lease would have parked with the tenant.[7]

For operators, RIDEA can be an attractive way to scale without surrendering the business: capital comes in against the real estate, the operator continues to run the homes under a management contract, and both sides share in improvement. But it is a genuine partnership, with the governance, reporting and control implications that follow – and it must be structured with one eye firmly on the competition regime, as the past six months have made unavoidable.

The CMA and Welltower: a new gravitational centre for deal-making

No development has reshaped the strategic calculus more than the Competition and Markets Authority’s investigation into Welltower’s recent UK acquisitions. The CMA opened its review in January 2026 into four completed transactions – covering homes managed by Barchester Healthcare, HC-One, Aria Care (including Asprey) and Danforth Care, together more than 600 operational homes plus a pipeline of consented sites, with a combined value north of £6 billion and some 46 individual transactions.[8] Because the deals had completed without prior notification, the CMA imposed initial enforcement orders in February requiring the businesses to be held separate pending its review.[9]

On 7 May 2026 the CMA concluded its Phase 1 review, finding a realistic prospect of a substantial lessening of competition (SLC) in local markets – including, in respect of the HC-One acquisition, concerns across residential and nursing care in a number of localities and a realistic prospect of an SLC across 30 local areas in total.[10] Welltower and its operating partner Apex were given until 14 May to offer undertakings in lieu of a Phase 2 reference. They did so, proposing to sell a number of care home properties and to reallocate the operation of certain other homes to a new operator.[11] In a decision dated 21 May and published on 27 May, the CMA found reasonable grounds to believe those undertakings (or a modified version) might be accepted in lieu of reference and will now consult on the undertakings and on the proposed purchaser(s).[12]

The wider lessons matter more than the specific remedy:

• Completion is not a safe harbour. Closing without notifying did not insulate these deals from scrutiny; it produced a more disruptive outcome, withhold-separate obligations imposed after completion and the prospect of forced divestments.

• Local market overlaps matter even in propco deals. The CMA looked past the headline national share – the portfolios together represent only a single-digit percentage of the UK market – to focus on concentration in specific localities and treated the combination of property ownership and operational influence as capable of giving rise to an SLC.

• Risk allocation belongs in the deal documents. Buyers and sellers should be explicit about who bears the cost and risk of CMA engagement, hold-separate obligations and any divestment remedy, including the financial mechanics of a forced sale.

• Voluntary pre-notification deserves serious thought for any large or strategically sensitive transaction and the evidentiary groundwork – board papers, internal analysis, third-party data, a clear articulation of commercial rationale and local positioning – should be prepared early.

For anyone advising on scaling strategies, competition clearance is no longer a footnote to a portfolio acquisition; it is a structural feature of the deal and one that can determine both timetable and value.

Government policy on health and social care funding

The investment case for any care home ultimately rests on the strength and durability of its income – and that income is heavily influenced by public policy. The Casey Commission, the Government’s independent commission into adult social care, is delivering in two phases: a medium-term plan in 2026 focused on making better use of existing resources and longer-term recommendations by 2028 setting the path towards a National Care Service.[13] Around £4.6 billion of additional adult social care funding has been signalled for 2028–29 compared with 2025–26, alongside reform of the Better Care Fund and a simplification that consolidates a range of grants into local authorities’ core funding allocations, with a refreshed CQC approach to assessing local authorities rolling out in parallel.[14]

For investors, the significance is twofold. First, genuine reform of how care is funded – and, in particular, the adequacy of local-authority fee rates relative to the cost of delivering care – remains unresolved and largely deferred to 2028. That uncertainty places a premium on the private-pay end of the market, where fee growth has been resilient and demand robust and it sharpens the divide between assets with strong self-pay catchments and those dependent on publicly funded placements. Second, the cost side is moving regardless of the funding side. The National Living Wage rose to £12.71 per hour in April 2026,[15] employer National Insurance contributions have increased with a sharply lower threshold that bites disproportionately on a part-time workforce[16] and a Fair Pay Agreement for the adult social care workforce is in prospect. Each of these compresses operator margins and, in turn, the rent cover and trading performance on which both lease-based and RIDEA investments depend.

The practical takeaway is that the quality of an income stream now turns on the funding mix as much as on occupancy: the self-pay/local-authority split, fee-uplift mechanisms and the operator’s ability to pass cost inflation through are first-order diligence questions rather than back-of-the-pack detail.

Geopolitical and cross-border factors

Two geopolitical currents bear directly on the sector. The first is workforce. The closure of the overseas recruitment route for care workers – with no fresh overseas hiring permitted below degree-equivalent roles since July 2025, tight restrictions on dependants, and intensified Home Office enforcement of sponsor compliance – has removed the principal supply valve the sector leaned on through the post-pandemic staffing crisis.[17] For a labour-intensive business already wrestling with wage inflation, that is a material constraint on growth and on margins and it makes the operational quality of any target – its recruitment, retention and reliance on agency staff – a sharper diligence point.

The second is capital. The UK has become the leading destination for cross-border investment into care homes, attracted by deep, resilient self-pay demand and a shortage of new stock.[18] US REITs have led that flow, advantaged by cheaper capital and the RIDEA structures discussed above; sovereign and overseas institutional money is active across adjacent healthcare assets too. That dependence on international capital is a strength in a liquid market, but it carries exposure to currency movements, divergent US and UK interest-rate paths, shifting trade and tariff dynamics and the possibility that global allocators rotate away from UK healthcare if relative returns compress. The flip side is opportunity: domestic REITs and UK investors, quieter while US capital led, are expected to become more active as conditions ease and a more competitive bidding field tends to support exit values.

What this means for scaling and exits

For operators, the routes to scale remain open but are more nuanced than in the last cycle. Debt can fund growth where covenant and catchment support it, but refinancing risk must be managed. Sale-and-leaseback and RIDEA-style partnerships both unlock capital – the former trading control for certainty, the latter retaining operational control while sharing upside – and the right choice depends on the operator’s appetite for risk and partnership.

For investors planning an exit, the fundamentals are favourable: record liquidity, sustained demand and a buyer pool spanning US, European and domestic capital. But value will increasingly accrue to assets that can demonstrate durable income – strong private-pay exposure, defensible local positioning, resilient staffing and a clean competition profile. The Welltower experience confirms that regulatory and structuring discipline now sits at the heart of value preservation, not at its margins.

The sector’s central paradox endures: abundant capital and undeniable demand, set against financing, regulatory, policy and workforce pressures that reward careful structuring and punish the opposite. Those who build competition analysis, funding-mix diligence and workforce resilience into their plans from the outset – rather than treating them as afterthoughts – will be best placed both to grow and, in time, to exit well.

This article is intended as general commentary and does not constitute legal advice. For advice on a specific transaction or situation, please contact Monica Macheng or learn more about our Social Care expertise.